Comerica Bank
TAK icon

Comerica Bank’s Takeda Pharmaceutical TAK Stock Holding History

Comerica Bank’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1M Sell
62,103
-1,145
-2% -$16K 0.01% 1439
2022
Q3 		$796K Buy
63,248
+3,984
+7% +$55.4K 0.01% 1585
2022
Q2 		$868K Sell
59,264
-998
-2% -$14.2K 0.01% 1601
2022
Q1 		$884K Sell
60,262
-1,587
-3% -$23.3K 0.01% 1639
2021
Q4 		$898K Sell
61,849
-5,301
-8% -$74.4K 0.01% 1629
2021
Q3 		$945K Sell
67,150
-125,189
-65% -$2.1M 0.01% 1712
2021
Q2 		$3.19M Buy
192,339
+240
+0.1% +$4.09K 0.02% 1010
2021
Q1 		$3.28M Buy
192,099
+6,372
+3% +$115K 0.02% 1030
2020
Q4 		$3.37M Buy
185,727
+6,759
+4% +$119K 0.02% 953
2020
Q3 		$2.98M Sell
178,968
-1,354
-0.8% -$24.7K 0.02% 857
2020
Q2 		$3.15M Buy
180,322
+9,397
+5% +$169K 0.02% 779
2020
Q1 		$3M Sell
170,925
-5,950
-3% -$108K 0.03% 671
2019
Q4 		$3.47M Sell
176,875
-427
-0.2% -$8.17K 0.03% 750
2019
Q3 		$3.13M Sell
177,302
-5,675
-3% -$98.1K 0.02% 787
2019
Q2 		$3.18M Sell
182,977
-2,823
-2% -$51.4K 0.03% 782
2019
Q1 		$3.68M Buy
185,800
+87,427
+89% +$1.76M 0.03% 700
2018
Q4 		$1.99M Buy
+98,373
New +$1.66M 0.02% 1107

Other funds holding TAK

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Comerica Bank's TAK Position: Q4 2022 in Review

Comerica Bank reduced its Takeda Pharmaceutical (TAK) stake by 1.8% in Q4 2022, selling an estimated $16K and leaving 62,103 shares worth $1M. The position accounts for 0.01% of the portfolio, ranked #1439.

Comerica Bank first reported a position in TAK in Q4 2018 and has held it in 17 quarters since. The position peaked at $3.68M in Q1 2019. 281 funds tracked by Wall St. Rank hold TAK as of Q4 2022.

  • Comerica Bank held 62,103 shares of Takeda Pharmaceutical worth $1M as of Q4 2022.
  • Comerica Bank sold 1,145 Takeda Pharmaceutical shares in Q4 2022, an estimated $16K.
  • Takeda Pharmaceutical made up 0.01% of Comerica Bank's portfolio in Q4 2022, its #1439 holding.
  • Comerica Bank first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 17 quarters since.
  • Comerica Bank's Takeda Pharmaceutical position peaked at $3.68M in Q1 2019.
  • 281 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2022.

Based on Comerica Bank's 13F filing for Q4 2022, filed 26 Jan 2023.